EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cranial Defect Reconstruction With Custom 3D‐Printed Hydroxyapatite Scaffolds Augmented With rhBMP‐2 or Dipyridamole in a Nonhuman Primate Model

Griffin P Bins iD, Heather A Burkart, William Molair, Samuel Kogan, Dominic A Massary, Angel Cabrera Pereira iD, Adem Aksu, Frank Reinauer, Daniel A Couture iD, Lukasz Witek iD, Christopher M Runyan iD

Journal of Tissue Engineering and Regenerative Medicine · 2026

DOI: 10.1155/term/2466910 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Tissue Engineering and Regenerative Medicine, 2026. Verfasst von Griffin P Bins und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Plastic and Reconstructive Surgery, Northwell Health, New York, New York, USA, northwell.edu. Hauptthemen laut MEDLINE: Bone Morphogenetic Protein 2, Tissue Scaffolds, Printing, Three-Dimensional, Transforming Growth Factor beta. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Reconstruction of critical‐sized bone defects, particularly in the cranio‐maxillofacial region, presents unique challenges due to the need for integration with adjacent well‐vascularized tissue and the absence of significant load‐bearing requirements. This study evaluated the clinical readiness of bone tissue engineering (BTE) for critically sized cranial defects using custom 3D‐printed hydroxyapatite scaffolds augmented with either recombinant human bone morphogenetic protein‐2 (rhBMP‐2) or dipyridamole (DIPY) in a highly translational nonhuman primate model.

Methods

Identical 5 × 5‐cm vertex guided craniotomies were created in 12 macaques: Three cynomolgus macaques served as negative controls to validate the critical size nature of the defect, while nine rhesus macaques underwent scaffold reconstruction. Subjects were divided into three groups: uncoated scaffolds ( n = 3), scaffolds augmented with rhBMP‐2 (Infuse® Medtronic, n = 3), and scaffolds coated with DIPY, an adenosine A 2A receptor (A 2A R) indirect agonist ( n = 3). Bone growth and integration were assessed over 12 months through serial CT scans, followed by ex vivo micro‐CT scanning, histology, and nanoindentation testing.

Results

Negative control subjects did not demonstrate new bone formation, confirming the critical defect model. Subjects treated with scaffolds through all treatment groups remained intact throughout the 12‐month follow‐up. The rhBMP‐2‐treated group exhibited bridging, ∼90% circumferentially, significantly greater than DIPY (∼9%) or the uncoated scaffold (10%) ( p < 0.001). Bone volume within rhBMP‐2‐treated scaffolds (7621 ± 145 mm 3 ) significantly exceeded that of DIPY (6466 ± 693 mm 3 , p = 0.03) and uncoated scaffold (6348 ± 663 mm 3 , p = 0.02) groups at 12 months. Quantitative histological micrograph analysis demonstrated that rhBMP‐2 scaffolds were associated with the highest bone ingrowth (∼64%) relative to DIPY (∼39%) and uncoated scaffolds (∼27%). Nanoindentation yielded superior mechanical properties (Young’s modulus and hardness) of newly generated bone with defects treated with rhBMP‐2 scaffolds ( p < 0.05).

Conclusions

Reconstructing critically sized cranial defects with custom 3D‐printed hydroxyapatite scaffolds was successful and yielded favorable results in this model. Scaffolds augmented with rhBMP‐2 demonstrated superior bone ingrowth, integration, and mechanical properties, highlighting their potential as a viable alternative to autografts and allograft materials for cranioplasty.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Morphogenetic Protein 2Tissue ScaffoldsPrinting, Three-DimensionalTransforming Growth Factor betaDurapatiteSkullDipyridamoleAnimalsRecombinant ProteinsMacaca mulattaHumansMale

Stichwörter der Autor:innen

animal modelbiomaterialscranioplastyreconstructiontissue engineering

Substanzen

Bone Morphogenetic Protein 2Recombinant ProteinsTransforming Growth Factor betaDurapatiterecombinant human bone morphogenetic protein-2Dipyridamole

Autor:innen und Institutionen

  • Division of Plastic and Reconstructive Surgery, Northwell Health, New York, New York, USA, northwell.edu.
  • Department of Comparative Medicine/Pathology and Department of Plastic and Reconstructive Surgery, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA, wakehealth.edu.
  • Department of Surgery, East Carolina University, Greenville, North Carolina, USA, ecu.edu.
  • Department of Plastic and Reconstructive Surgery, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA, wakehealth.edu.
  • Department of Biomedical Engineering, City College of New York, New York, New York, USA, cuny.edu.
  • Implants Biomaterials-Division Implants, KLS Martin SE & Co. KG, Mühlheim, Germany.

ORCID-Profile: Griffin P Bins, Angel Cabrera Pereira, Daniel A Couture, Lukasz Witek, Christopher M Runyan

Zitieren

APA

Bins, G. P., Burkart, H. A., Molair, W., Kogan, S., Massary, D. A., Pereira, A. C., Aksu, A., Reinauer, F., Couture, D. A., Witek, L., & Runyan, C. M. (2026). Cranial Defect Reconstruction With Custom 3D‐Printed Hydroxyapatite Scaffolds Augmented With rhBMP‐2 or Dipyridamole in a Nonhuman Primate Model. Journal of Tissue Engineering and Regenerative Medicine. https://doi.org/10.1155/term/2466910

Vancouver

Bins GP, Burkart HA, Molair W, Kogan S, Massary DA, Pereira AC, et al. Cranial Defect Reconstruction With Custom 3D‐Printed Hydroxyapatite Scaffolds Augmented With rhBMP‐2 or Dipyridamole in a Nonhuman Primate Model. Journal of Tissue Engineering and Regenerative Medicine. 2026. doi:10.1155/term/2466910

BibTeX
@article{Bins2026,
  author = {Bins, Griffin P and Burkart, Heather A and Molair, William and Kogan, Samuel and Massary, Dominic A and Pereira, Angel Cabrera and Aksu, Adem and Reinauer, Frank and Couture, Daniel A and Witek, Lukasz and Runyan, Christopher M},
  title = {Cranial Defect Reconstruction With Custom 3D‐Printed Hydroxyapatite Scaffolds Augmented With rhBMP‐2 or Dipyridamole in a Nonhuman Primate Model},
  journal = {Journal of Tissue Engineering and Regenerative Medicine},
  year = {2026},
  doi = {10.1155/term/2466910}
}
Kostenlos starten →